Next Generation Sequencing (NGS) Market, By Product & Service (Pre-Sequencing Products & Services, NGS Consumables, Platforms, & Services for Platforms, Sequencing Services, NGS Data Analysis, Storage, and Management), Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Sequencing Technologies), Application (Diagnostics, Drug Discovery, Agricultural & Animal Research, Other Applications), End-User (Academic Institutes & Research Centres, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Next Generation Sequencing (NGS) Market
Next generation sequencing (NGS) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 18.28% in the above-mentioned forecast period. Increase in the continuous technological advancement in NGS platform drives the next generation sequencing (NGS) market.
NGS or next-generation sequencing is also known as massively parallel sequencing technology. NGS allows researchers to research on various applications including speed, scalability, and ultra-high throughput and also study biological systems at a next level. NGS allows researchers to rapidly sequence whole genomes.
Reducing price of NGS installation is the vital factor escalating the market growth, also reducing price of NGS installation, rise in the proper reimbursement and improving regulatory scenario and continuous upsurge in applications of next generation sequencing are the major factors among others driving the next generation sequencing (NGS) market. Moreover, rise in the technological advancements and modernization in the healthcare sector and rise in the demand from emerging economies will further create new opportunities for next generation sequencing (NGS) market in the forecasted period of 2021-2028.
However, less number of skilled personnel, rise in the concern about standardization of NGS based diagnostics and legal and ethical restrictions are the major factors among others acting as restraints, and will further challenge the growth of next generation sequencing (NGS) market in the forecast period mentioned above.
Next generation sequencing (NGS) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research next generation sequencing (NGS) market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Next Generation Sequencing (NGS) Market Scope and Market Size
Next generation sequencing (NGS) market is segmented on the basis of products & services, technology, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of products & services, the next generation sequencing (NGS) market is segmented into pre-sequencing products & services, NGS consumables, platforms, & services for platforms, sequencing services, NGS data analysis, storage, and management. Pre-sequencing products & services have been further segmented into sample preparation. NGS consumables, platforms, & services for platforms have been further segmented into NGS consumables, NGS platforms and services for NGS platforms. Sequencing Services have been further segmented into exome & targeted re-sequencing and custom panels, RNA-seq, whole-genome sequencing & de novo sequencing and other sequencing services. NGS data analysis, storage, and management has been further segmented into NGS data analysis software & workbenches, NGS data analysis services, NGS storage, management, and cloud computing solutions.
- Based on technology, the next generation sequencing (NGS) market is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing and other sequencing technologies.
- Based on application, the next generation sequencing (NGS) market is segmented into diagnostics, drug discovery, agricultural & animal research and other applications. Diagnostics have been further segmented into cancer diagnostics, infectious disease diagnostics, reproductive health diagnostics and other diagnostic applications.
- Based on end-user, the next generation sequencing (NGS) market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies and other end users.
Next Generation Sequencing (NGS) Market Country Level Analysis
Next generation sequencing (NGS) market is analysed and market size insights and trends are provided by country, products & services, technology, application and end-user as referenced above.
The countries covered in the next generation sequencing (NGS) market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia- Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East & Africa.
North America dominates the next generation sequencing (NGS) market due to increase in the proper reimbursement and improving regulatory scenario and continuous upsurge in applications of next generation sequencing in this region. Asia-Pacific is the expected region in terms of growth in next generation sequencing (NGS) market due to rise in the proper reimbursement and improving regulatory scenario and continuous upsurge in applications of next generation sequencing in this region.
The country section of the next generation sequencing (NGS) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Next generation sequencing (NGS) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for next generation sequencing (NGS) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the next generation sequencing (NGS) market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Next Generation Sequencing (NGS) Market Share Analysis
Next generation sequencing (NGS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to next generation sequencing (NGS) market.
The major players covered in the next generation sequencing (NGS) market report are Illumina, Inc., BGI, Eurofins Scientific, PerkinElmer Inc., Macrogen Inc., DNA Link, Inc., Genotypic Technology Pvt Ltd, WuXi AppTec, GENEWIZ, Takara Bio Inc., SciGenom Labs Pvt. Ltd, Theragen Etex Co., Ltd., LGC Biosearch Technologies, Oxford Gene Technology IP Limited, Sysmex Inostics, Zymo Research, Source BioScience, Novogene Corporation among other domestic and regional players. Market share data is available for Europe only. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Next Generation Sequencing (NGS) Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
SKU-